• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Clearlake Capital-Backed symplr To Acquire API Healthcare

Share:

February 25, 2019

Strategic acquisition creates the healthcare industry’s only large-scale provider of governance, risk and compliance and human capital management software solutions

symplr, a leading healthcare governance, risk and compliance software-as-a-service platform, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”), announced that it has signed a definitive agreement to acquire API Healthcare, a leading provider of healthcare human capital management software solutions, from Veritas Capital. Financial terms were not disclosed.

The combination of symplr and API will deliver the healthcare industry’s only fully integrated GRC and HCM SaaS platform of scale, offering an end-to-end solution encompassing provider data management, credentialing and workforce management, addressing the full spectrum of labor regulatory requirements while also improving patient outcomes and quality of service.

API is a leading provider of healthcare HCM software solutions, automating workforce management to improve financial, clinical and operational outcomes. Based in Hartford, Wisconsin, API offers time and attendance, staffing and scheduling, patient classification, HR, payroll and analytics software to over 375 hospitals and health systems.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“This is a transformational acquisition that further expands our healthcare software footprint and broadens our SaaS offerings by strengthening symplr’s existing GRC platform and adding new workforce management capabilities,” said Rick Pleczko, CEO, and Tres Thompson, COO & CFO, of symplr. “Together with API, symplr will continue to pursue the mission of providing software solutions that help healthcare organizations meet regulatory compliance requirements and increase operational efficiency. This is a powerful combination for our customers, partners and team.”

“As symplr continues to uniquely address the increasing demand for software solutions to drive efficiency in the healthcare industry, we believe this acquisition will significantly expand symplr’s market opportunity and accelerate its growth trajectory,” said Prashant Mehrotra and Paul Huber of Clearlake. “We are excited to support Rick, Tres and the team as they drive growth and consolidation in the industry, both organically and inorganically, and continue to provide trusted and valued technology to healthcare providers and professionals across the globe.”

“We are very excited to be joining the symplr family,” said Bill Christy, CEO at API. “The combination of our organizations positions us well to continue to drive meaningful outcomes for our customers across the healthcare market.”

Robert W. Baird served as financial advisor to symplr and Clearlake. William Blair & Company served as financial advisor to API and Veritas Capital. Financing for the transaction was led by Antares Capital, Bain Capital Credit, Golub Capital, Adams Street Partners and New Mountain Finance Corporation.

Date: February 25, 2019

Source: Business Journal

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • ConcertAI Scores $150M, Valuation Skyrockets to Nearly $2BConcertAI Scores $150M, Valuation Skyrockets to Nearly $2B
  • Leading Prenatal App Babyscripts Announces Partnership with Axia Women’s HealthLeading Prenatal App Babyscripts Announces Partnership with Axia Women’s Health
  • Indian Digital Therapeutics Firm Launches COVID-19 Recovery Programme for Diabetic PatientsIndian Digital Therapeutics Firm Launches COVID-19 Recovery Programme for Diabetic Patients
  • Fitbit Patent Reveals It Could be Working on a Health Monitoring RingFitbit Patent Reveals It Could be Working on a Health Monitoring Ring
  • Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce PlatformCannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform
  • Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CROCatalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO
  • Artificial Intelligence Solution Improves Clinical Trial RecruitmentArtificial Intelligence Solution Improves Clinical Trial Recruitment
  • Infermedica Launches Ai Feature to Connect Patients with SpecialistsInfermedica Launches Ai Feature to Connect Patients with Specialists

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications